KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dillard'S (DDS) Cash & Equivalents (2016 - 2026)

Dillard'S's Cash & Equivalents history spans 18 years, with the latest figure at $861.5 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 20.0% year-over-year to $861.5 million; the TTM value through Jan 2026 reached $861.5 million, up 20.0%, while the annual FY2026 figure was $861.5 million, 20.0% up from the prior year.
  • Cash & Equivalents reached $861.5 million in Q1 2026 per DDS's latest filing, down from $1.1 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.1 billion in Q4 2025 to a low of $492.9 million in Q3 2022.
  • Average Cash & Equivalents over 5 years is $818.5 million, with a median of $842.0 million recorded in 2023.
  • The largest YoY upside for Cash & Equivalents was 98.91% in 2022 against a maximum downside of 26.38% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $532.7 million in 2022, then surged by 58.06% to $842.0 million in 2023, then grew by 16.44% to $980.4 million in 2024, then grew by 17.22% to $1.1 billion in 2025, then fell by 25.04% to $861.5 million in 2026.
  • Per Business Quant, the three most recent readings for DDS's Cash & Equivalents are $861.5 million (Q1 2026), $1.1 billion (Q4 2025), and $1.0 billion (Q3 2025).